Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure

Nephrol Dial Transplant. 2004 May;19 Suppl 2:ii1-47. doi: 10.1093/ndt/gfh1032.
No abstract available

Publication types

  • Guideline
  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia / blood
  • Anemia / diagnosis
  • Anemia / etiology*
  • Anemia / therapy*
  • Anemia, Sickle Cell / blood
  • Anemia, Sickle Cell / physiopathology
  • Arteriovenous Shunt, Surgical
  • Blood Transfusion
  • Chronic Disease
  • Darbepoetin alfa
  • Diabetic Nephropathies / blood
  • Diabetic Nephropathies / physiopathology
  • Disease Progression
  • Erythropoiesis / drug effects
  • Erythropoietin / administration & dosage
  • Erythropoietin / analogs & derivatives*
  • Erythropoietin / therapeutic use
  • Europe
  • Evidence-Based Medicine
  • Ferritins / blood
  • Hematocrit
  • Hematologic Tests
  • Hemoglobinometry
  • Hemoglobins / analysis
  • Hemorheology
  • Humans
  • Iron / administration & dosage
  • Iron / blood
  • Iron / therapeutic use
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / complications*
  • Nutritional Physiological Phenomena
  • Oxidative Stress
  • Quality of Life
  • Recombinant Proteins
  • Red-Cell Aplasia, Pure / immunology
  • Renal Dialysis
  • Review Literature as Topic
  • Transferrin / analysis
  • Treatment Failure
  • Vitamin E / therapeutic use

Substances

  • Hemoglobins
  • Recombinant Proteins
  • Transferrin
  • Erythropoietin
  • Vitamin E
  • Darbepoetin alfa
  • Ferritins
  • Iron